% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • qdelfan qdelfan Jun 29, 2012 10:12 AM Flag

    Phase 2A 809/770 data

    The final data confirms efficacy safety and the potential ideal dose range to treat up to half the CF population. The bulls now have another great buying oppportunity, and the bears who haven't covered their short positions yet will certaily be wishing they did.

86.02+1.02(+1.20%)4:00 PMEDT